Update on EBV monitoring, detection and therapy in PTLD after solid organ transplant

ISSN： 1746-0794

Source： Future Virology, Vol.5, Iss.3, 2010-05, pp. : 287-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A CHOP regimen is effective for post-transplant lymphoproliferative disorders (PTLD) that have progressed after first-line therapy with rituximab

Inpharma, Vol. 1, Iss. 1588, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients: Update on Epidemiology, Risk Factors, and Management

By Tessari Gianpaolo Girolomoni Giampiero

Dermatologic Surgery, Vol. 38, Iss. 10, 2012-10 ,pp. : 1622-1630

Elsevier

Access to resources Recommend Favorite

Solid organ transplant and the risk of cancer

Reactions Weekly, Vol. 1, Iss. 1378, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Issues of Adherence to Immunosuppressant Therapy After Solid-Organ Transplantation

By Chisholm M.A.

Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. : 567-575

Adis International

Access to resources Recommend Favorite

Reduction in the Incidence of Squamous Cell Carcinoma in Solid Organ Transplant Recipients Treated with Cyclic Photodynamic Therapy

By WILLEY ANDREA MEHTA SHEETAL LEE PETER K.

Dermatologic Surgery, Vol. 36, Iss. 5, 2010-05 ,pp. : 652-658

Elsevier

Access to resources Recommend Favorite